What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and heart protection - CNN
- What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and heart protection CNN
- Weight loss drug could reduce heart attack risk by 20%, study finds The Guardian
- Wegovy weight loss sustained for four years in trial, Novo Nordisk says Reuters
- Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial Nature.com
- Weight-loss jab 'cuts heart disease deaths by 20%' The Times